These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 17922005)
1. ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanism. Luo L; Parrish CA; Nevins N; McNulty DE; Chaudhari AM; Carson JD; Sudakin V; Shaw AN; Lehr R; Zhao H; Sweitzer S; Lad L; Wood KW; Sakowicz R; Annan RS; Huang PS; Jackson JR; Dhanak D; Copeland RA; Auger KR Nat Chem Biol; 2007 Nov; 3(11):722-6. PubMed ID: 17922005 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of inhibition of human KSP by ispinesib. Lad L; Luo L; Carson JD; Wood KW; Hartman JJ; Copeland RA; Sakowicz R Biochemistry; 2008 Mar; 47(11):3576-85. PubMed ID: 18290633 [TBL] [Abstract][Full Text] [Related]
3. Thermodynamics of nucleotide and inhibitor binding to wild-type and ispinesib-resistant forms of human kinesin spindle protein. Sheth PR; Basso A; Duca JS; Lesburg CA; Ogas P; Gray K; Nale L; Mannarino AF; Prongay AJ; Le HV Biochemistry; 2009 Nov; 48(46):11045-55. PubMed ID: 19824700 [TBL] [Abstract][Full Text] [Related]
4. Discovery and biochemical characterization of selective ATP competitive inhibitors of the human mitotic kinesin KSP. Rickert KW; Schaber M; Torrent M; Neilson LA; Tasber ES; Garbaccio R; Coleman PJ; Harvey D; Zhang Y; Yang Y; Marshall G; Lee L; Walsh ES; Hamilton K; Buser CA Arch Biochem Biophys; 2008 Jan; 469(2):220-31. PubMed ID: 17999913 [TBL] [Abstract][Full Text] [Related]
5. Conformation-dependent ligand regulation of ATP hydrolysis by human KSP: activation of basal hydrolysis and inhibition of microtubule-stimulated hydrolysis by a single, small molecule modulator. Luo L; Carson JD; Molnar KS; Tuske SJ; Coales SJ; Hamuro Y; Sung CM; Sudakin V; Auger KR; Dhanak D; Jackson JR; Huang PS; Tummino PJ; Copeland RA J Am Chem Soc; 2008 Jun; 130(24):7584-91. PubMed ID: 18491908 [TBL] [Abstract][Full Text] [Related]
6. Developments of kinesin spindle protein inhibitors as antitumor agents based on the five-membered heterocycle scaffolds. Zhao GD; Wan RZ; Liu ZP Curr Med Chem; 2014; 21(23):2691-701. PubMed ID: 24606497 [TBL] [Abstract][Full Text] [Related]
7. Novel benzimidazole inhibitors bind to a unique site in the kinesin spindle protein motor domain. Sheth PR; Shipps GW; Seghezzi W; Smith CK; Chuang CC; Sanden D; Basso AD; Vilenchik L; Gray K; Annis DA; Nickbarg E; Ma Y; Lahue B; Herbst R; Le HV Biochemistry; 2010 Sep; 49(38):8350-8. PubMed ID: 20718440 [TBL] [Abstract][Full Text] [Related]
8. Recent progress in the identification and clinical evaluation of inhibitors of the mitotic kinesin KSP. Knight SD; Parrish CA Curr Top Med Chem; 2008; 8(10):888-904. PubMed ID: 18673173 [TBL] [Abstract][Full Text] [Related]
10. Kinesin spindle protein inhibitors in cancer: a patent review (2008 - present). Jiang C; You Q Expert Opin Ther Pat; 2013 Dec; 23(12):1547-60. PubMed ID: 23978071 [TBL] [Abstract][Full Text] [Related]
11. Ligand- and structure-based in silico studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents. Balakumar C; Ramesh M; Tham CL; Khathi SP; Kozielski F; Srinivasulu C; Hampannavar GA; Sayyad N; Soliman ME; Karpoormath R J Biomol Struct Dyn; 2018 Nov; 36(14):3687-3704. PubMed ID: 29064326 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation and molecular docking studies of flavone and isoflavone derivatives as a novel class of KSP (kinesin spindle protein) inhibitors. Dong JJ; Li QS; Liu ZP; Wang SF; Zhao MY; Yang YH; Wang XM; Zhu HL Eur J Med Chem; 2013; 70():427-33. PubMed ID: 24184776 [TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. Tao W; South VJ; Zhang Y; Davide JP; Farrell L; Kohl NE; Sepp-Lorenzino L; Lobell RB Cancer Cell; 2005 Jul; 8(1):49-59. PubMed ID: 16023598 [TBL] [Abstract][Full Text] [Related]
14. Strategies for the NMR-based identification and optimization of allosteric protein kinase inhibitors. Jahnke W; Blommers MJ; Fernández C; Zwingelstein C; Amstutz R Chembiochem; 2005 Sep; 6(9):1607-10. PubMed ID: 16028302 [No Abstract] [Full Text] [Related]
15. Structure-activity relationships of carboline and carbazole derivatives as a novel class of ATP-competitive kinesin spindle protein inhibitors. Takeuchi T; Oishi S; Watanabe T; Ohno H; Sawada J; Matsuno K; Asai A; Asada N; Kitaura K; Fujii N J Med Chem; 2011 Jul; 54(13):4839-46. PubMed ID: 21599002 [TBL] [Abstract][Full Text] [Related]
17. Discovery of allosteric inhibitors of kinesin spindle protein (KSP) for the treatment of taxane-refractory cancer: MK-0731 and analogs. Cox CD; Garbaccio RM Anticancer Agents Med Chem; 2010 Nov; 10(9):697-712. PubMed ID: 21235439 [TBL] [Abstract][Full Text] [Related]
18. Progress on kinesin spindle protein inhibitors as anti-cancer agents. Zhang Y; Xu W Anticancer Agents Med Chem; 2008 Aug; 8(6):698-704. PubMed ID: 18690830 [TBL] [Abstract][Full Text] [Related]
19. Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP. Cox CD; Breslin MJ; Mariano BJ; Coleman PJ; Buser CA; Walsh ES; Hamilton K; Huber HE; Kohl NE; Torrent M; Yan Y; Kuo LC; Hartman GD Bioorg Med Chem Lett; 2005 Apr; 15(8):2041-5. PubMed ID: 15808464 [TBL] [Abstract][Full Text] [Related]
20. Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5. Maliga Z; Kapoor TM; Mitchison TJ Chem Biol; 2002 Sep; 9(9):989-96. PubMed ID: 12323373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]